Vitality Watch

Dossier pubmed observational 05-oct-2026
Human cohort, case-control, or epidemiological association

Accelerated Biological Aging and Risk of Early-Onset Colorectal Cancer: Findings from a Large Prospective East Asian Cohort.

Key claim: In nearly 200,000 Korean adults under 50, accelerated biological aging by PhenoAge was independently associated with about 93% higher risk of early-onset colorectal adenocarcinoma, but not neuroendocrine tumors.

Abstract

BACKGROUND & AIMS: The global increase in young-onset colorectal cancer (CRC, diagnosed before age 50) necessitates improved risk stratification. Biological age, which better reflects physiological deterioration than chronological age, may serve as a crucial indicator of disease susceptibility. We examined the association between accelerated biological aging and early-onset colorectal adenocarcinoma (EOCRC-AC) risk. METHODS: In a prospective cohort of 198,491 Korean adults under 50 years of chronological age, we estimated biological age using Phenotypic Age (PhenoAge), derived from nine routine blood biomarkers, with acceleration calculated as the residual from regressing biological age on chronological age. Cox proportional hazards models, adjusted for demographic, behavioral, and clinical factors, examined the association between biological age acceleration and incident EOCRC-AC, with colorectal neuroendocrine tumors (EOCRC-NET) analyzed as a comparator outcome. RESULTS: Over a median follow-up of 7.7 years, 127 incident EOCRC-AC and 142 EOCRC-NET were identified through linkage with the National Cancer Registry. Individuals with biological age greater than chronological age (accelerated biological aging) had a 93% higher risk of EOCRC-AC (hazard ratio [HR] 1.93, 95% CI 1.28-2.91), with particularly strong associations for colon adenocarcinoma (HR 2.32, 95% CI 1.38-3.89). Associations remained consistent across subgroups including adults younger than 45 years and lag-time sensitivity analyses. In contrast, no consistent association was observed for EOCRC-NET. CONCLUSION: Accelerated biological aging is independently associated with increased EOCRC-AC risk. Biological aging measures could complement chronological age-based criteria, improving risk stratification and identifying younger individuals who may benefit from earlier or tailored screening strategies.

Why this matters

Early-onset colorectal cancer is rising in adults under 50 while chronological age alone offers little stratification below standard screening thresholds. A clinical-lab aging clock pulling signal out of routine bloodwork, validated in a large East Asian prospective cohort against an adenocarcinoma-specific outcome, is a concrete test of whether phenotypic aging measures earn their place in cancer risk layering beyond their usual mortality-prediction use. The histology-specific effect (adenocarcinoma yes, neuroendocrine no) also pushes back on treating PhenoAge as a generic ‘cancer risk’ readout.

Source

Link

Briefing card

Accelerated Biological Aging and Risk of Early-Onset Colorectal Cancer: Findings from a Large Prospective East Asian Cohort.
Stage: observational · pubmed · 05-oct-2026

If you are under 50 and your clinician reads PhenoAge off a standard blood panel, this cohort found accelerated PhenoAge tracked early-onset colorectal adenocarcinoma risk but not neuroendocrine colorectal tumors.

In nearly 200,000 Korean adults under 50, accelerated biological aging by PhenoAge was independently associated with about 93% higher risk of early-onset colorectal adenocarcinoma, but not neuroendocrine tumors.

Cross-references (0)

None recorded — doctrine links and citations appear here as scans and citation sweeps find them.

External: doi:10.1016/j.cgh.2026.09.039

build build 880 · 2bcef25 · 2026-11-18